1590. Updated Aminoglycoside (AG) MIC Breakpoints (BP) to Minimize Adverse Events and Improve Outcome: Impact on Susceptibility (S) Rates

BACKGROUND: In 2016 USCAST, the National Advisory Committee (NAC) for the United States (US) to EUCAST, undertook the re-evaluation of the in vitro susceptibility (AST) test interpretive criteria (IC) for gentamicin (GM), tobramycin (TO) and amikacin (AK) against Enterobacteriaceae (ENT), P. aerugin...

詳細記述

保存先:
書誌詳細
出版年:Open Forum Infect Dis
主要な著者: Pfaller, Michael A, Flamm, Robert K, Ambrose, Paul G, Andes, David, Bradley, John S, Bhavnani, Sujata M, Jones, Ronald N
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2019
主題:
Abstracts
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6809765/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.1454
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料